Meg Holland

Meg Holland, who has a BA in Human Biology from Stanford University, has held various positions in companies such as Accenture, Epocrates, and Apixio. Currently serving as the Executive Vice President at Apixio, Meg has extensive experience in overseeing risk adjustment, health data management, customer operations, and delivery. With an MBA from Stanford University Graduate School of Business, Meg has a strong background in health care strategy consulting and policy analysis, making their a valuable asset in the healthcare industry.